Clinical Trial Detail

NCT ID NCT02231775
Title Combi-Neo Study for Stage IV Melanoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

melanoma

Therapies

Dabrafenib + Trametinib

Age Groups: adult

No variant requirements are available.